X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (503) 503
index medicus (370) 370
monoclonal gammopathy (327) 327
male (298) 298
female (293) 293
middle aged (279) 279
aged (265) 265
hematology (249) 249
multiple myeloma (240) 240
undetermined significance (212) 212
adult (182) 182
oncology (176) 176
risk factors (161) 161
aged, 80 and over (148) 148
multiple-myeloma (144) 144
prevalence (127) 127
monoclonal gammopathy of undetermined significance - epidemiology (115) 115
prognosis (108) 108
multiple myeloma - epidemiology (103) 103
risk (99) 99
disease progression (92) 92
cancer (90) 90
monoclonal gammopathy of undetermined significance (80) 80
retrospective studies (80) 80
multiple myeloma - diagnosis (77) 77
monoclonal gammopathy of undetermined significance - diagnosis (70) 70
article (67) 67
diagnosis (66) 66
mgus (66) 66
incidence (65) 65
paraproteinemias - epidemiology (64) 64
epidemiology (63) 63
research (61) 61
long-term (60) 60
medicine, general & internal (56) 56
monoclonal gammopathies (55) 55
care and treatment (54) 54
multiple myeloma - genetics (54) 54
multiple myeloma - pathology (51) 51
progression (51) 51
case-control studies (50) 50
follow-up studies (50) 50
immunoglobulins (49) 49
abridged index medicus (47) 47
internal medicine (47) 47
hemic and lymphatic diseases (46) 46
multiple myeloma - etiology (46) 46
united-states (46) 46
cohort studies (45) 45
myeloma (45) 45
undetermined significance mgus (45) 45
development and progression (44) 44
bone marrow (43) 43
monoclonal gammopathy of undetermined significance - complications (43) 43
survival (43) 43
analysis (42) 42
health aspects (42) 42
stem-cell transplantation (42) 42
multiple myeloma - therapy (41) 41
young adult (41) 41
chronic lymphocytic-leukemia (39) 39
gammopathy (39) 39
adolescent (38) 38
monoclonal gammopathy of undetermined significance - etiology (37) 37
paraproteinemias - diagnosis (37) 37
lymphoma (36) 36
medicine & public health (36) 36
follow-up (35) 35
proteins (35) 35
disease (34) 34
hematology, oncology and palliative medicine (34) 34
transplantation (34) 34
leukemia (33) 33
comorbidity (32) 32
treatment outcome (32) 32
immunology (31) 31
medical research (31) 31
multiple myeloma - immunology (31) 31
multiple myeloma - mortality (31) 31
population (30) 30
registries (30) 30
monoclonal gammopathy of undetermined significance - immunology (29) 29
paraproteinemias - complications (29) 29
bone marrow - pathology (28) 28
genetic predisposition to disease (28) 28
lymphomas (28) 28
medical and health sciences (28) 28
medicin och hälsovetenskap (28) 28
monoclonal gammopathy of undetermined significance - blood (28) 28
monoclonal gammopathy of undetermined significance - pathology (28) 28
genetic aspects (27) 27
multiple myeloma - drug therapy (27) 27
age factors (26) 26
clinical medicine (26) 26
diagnosis, differential (26) 26
igm monoclonal gammopathy (26) 26
immune system diseases (26) 26
multiple myeloma - complications (26) 26
pathogenesis (26) 26
risk assessment (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (577) 577
French (11) 11
Spanish (5) 5
Japanese (3) 3
Italian (2) 2
Czech (1) 1
Danish (1) 1
German (1) 1
Korean (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Blood, ISSN 0006-4971, 03/2013, Volume 121, Issue 13, pp. 2522 - 2528
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2009, Volume 147, Issue 1, pp. 22 - 42
Journal Article
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2017, Volume 92, Issue 5, pp. 838 - 850
Abstract Monoclonal gammopathies comprise a spectrum of clonal plasma cell disorders that include monoclonal gammopathy of undetermined significance, multiple... 
Internal Medicine | Myeloablative Agonists - therapeutic use | Peripheral Nervous System Diseases - diagnosis | Monoclonal Gammopathy of Undetermined Significance - complications | Prognosis | Humans | Demyelinating Autoimmune Diseases, CNS - diagnosis | Demyelinating Autoimmune Diseases, CNS - immunology | Rituximab - therapeutic use | Monoclonal Gammopathy of Undetermined Significance - epidemiology | Demyelinating Autoimmune Diseases, CNS - etiology | Peripheral Nervous System Diseases - epidemiology | Peripheral Nervous System Diseases - etiology | Plasmapheresis - methods | Diagnosis, Differential | Biomarkers - analysis | Peripheral Nervous System Diseases - therapy | Glycoproteins - adverse effects | Vidarabine - analogs & derivatives | Immunoglobulins - administration & dosage | Vidarabine - therapeutic use | Administration, Intravenous | Demyelinating Autoimmune Diseases, CNS - epidemiology | Monoclonal Gammopathy of Undetermined Significance - immunology | Glycoproteins - analysis | Immunologic Factors - therapeutic use | Care and treatment | Polyneuropathies | Monoclonal antibodies | Physiological aspects | Development and progression | Research | Diagnosis | Risk factors | Neurosciences | Immunoglobulins | Disease | Hematology | Multiple myeloma | Glycoproteins | Peripheral neuropathy | Medical diagnosis | Patients | Epidemiology | Studies | Proteins | Neurology | Population | Psychiatry
Journal Article
Haematologica, ISSN 0390-6078, 06/2012, Volume 97, Issue 6, pp. 854 - 858
Journal Article
Blood, ISSN 0006-4971, 04/2014, Volume 123, Issue 16, pp. 2513 - 2517
Journal Article
Molecular medicine (Cambridge, Mass.), ISSN 1076-1551, 06/2018, Volume 24, Issue 1, pp. 30 - 13
Journal Article